arrow_back Trending Legislation
Share share

Supporting Fentanyl Awareness Day: Warning Against Counterfeit Pills and Youth Risk

The US Senate supports National Fentanyl Awareness Day to boost public knowledge, especially among youth and families, about the deadly threat posed by counterfeit pills laced with fentanyl. The resolution highlights that fake pills, often sold online, frequently contain lethal doses, making awareness crucial for public health and safety. Fentanyl is now the leading cause of drug-induced deaths among young people.
Key points
Drug Safety Alert: Counterfeit pills, often marketed as legitimate prescription drugs, are widely available and frequently contain lethal doses of fentanyl (6 out of 10 tested pills are potentially deadly).
Youth Mortality Crisis: Fentanyl is involved in more deaths of young people than all other drug types combined, emphasizing the need for immediate public education and awareness.
National Awareness: The resolution designates May 9th as National Fentanyl Awareness Day to support law enforcement efforts and increase nationwide understanding of this critical public health threat.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Adopted
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
A resolution supporting the mission and goals of National Fentanyl Awareness Day in 2023, including increasing individual and public awareness of the impact of fake or counterfeit fentanyl pills on families and young people.
Print number: SRES 215
Sponsor: Sen. Feinstein, Dianne [D-CA]
Process start date: 2023-05-17
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Supporting Fentanyl Awareness Day: Warning Against Counterfeit Pills and Youth Risk

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is SRES 215.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-05-17.

What are the main provisions?

Key points include:

  • Drug Safety Alert: Counterfeit pills, often marketed as legitimate prescription drugs, are widely available and frequently contain lethal doses of fentanyl (6 out of 10 tested pills are potentially deadly).
  • Youth Mortality Crisis: Fentanyl is involved in more deaths of young people than all other drug types combined, emphasizing the need for immediate public education and awareness.
  • National Awareness: The resolution designates May 9th as National Fentanyl Awareness Day to support law enforcement efforts and increase nationwide understanding of this critical public health threat.

What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Feinstein, Dianne [D-CA].

What is the latest detailed status?

The latest detailed status is: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S1712; text: CR S1709)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-30.

Analysis and Potential Impact of SRES 215

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health Security